sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Acute Lung Injury Market Scope And Analysis

  • Report Code : TIPRE00025720
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 102
Buy Now

North America Acute Lung Injury Market Scope and Analysis by 2028

Buy Now

North America Acute Lung Injury Market Report North America Acute Lung Injury Market Size and Share North America Acute Lung Injury Market Scope and Analysis

North America Acute Lung Injury Market Report Scope

Report Attribute Details
Market size in 2021 US$ 201.93 Million
Market Size by 2028 US$ 280.16 Million
Global CAGR (2021 - 2028) 4.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Therapy
  • Mechanical Ventilation
  • Fluid Management
  • Pharmacotherapy
  • Adjunctive Procedures
By End User
  • Hospitals
  • Ambulatory Surgery Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Angion
  • Asklepion Pharmaceuticals LLC
  • GlaxoSmithKline Plc
  • Qx Therapeutics Inc
  • ReAlta Life Sciences Inc
  • Stemedica Cell Technologies Inc
  • Windtree Therapeutics Inc